Al Anta, T., Al Shehadat, O., Taneera, J., Aleidi, S. M., Abuhelwa, A. A., Alzoubi, K. H., . . . Bustanji, Y. (Jan-Mar2026). Dual inhibition of PI3K and mTOR in cancer therapy: Mechanisms, clinical potential, and future perspectives. Pharmacy Practice (1886-3655), 24(1), 1-14.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Al Anta, Tasneem, et al. "Dual Inhibition of PI3K and MTOR in Cancer Therapy: Mechanisms, Clinical Potential, and Future Perspectives."
Pharmacy Practice (1886-3655) 24, no. 1 (Jan-Mar2026): 1-14.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Al Anta, Tasneem, et al. "Dual Inhibition of PI3K and MTOR in Cancer Therapy: Mechanisms, Clinical Potential, and Future Perspectives."
Pharmacy Practice (1886-3655), vol. 24, no. 1, Jan-Mar2026, pp. 1-14.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.